By pausing DMARDs, you may be ‘starting the cascade of getting the patient into trouble by interrupting therapy that’s ...

Adverse events from disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis decline by as much as 25% after the drugs are established on the market, according to data published ...

There are several effective treatments for RA, including DMARDs and biologics. Both types of medications control rheumatoid arthritis by lowering the inflammation that fuels it, but there are ...

Usually with rheumatoid arthritis, DMARDs are the first line of therapy for a lot of patients. DMARDs are Disease-Modifying Antirheumatic Drug that are usually oral. And they basically work by ...

A major Medicare study shows that while long-term steroid use declines after diagnosis of late-onset rheumatoid arthritis, a ...

In patients with RA, BMI affects cardiovascular risk, differing by anti–citrullinated protein antibody (ACPA) status and ...

Rheumatoid arthritis (RA) is a chronic ... pharmacotherapy with one or more disease-modifying antirheumatic drugs (DMARDs), typically supported by non-steroidal anti-inflammatory drugs (NSAIDs ...

Based on clinical trial data, abatacept was not associated with increased malignancy risks in RA or PsA; observational data indicated a higher risk vs other b/tsDMARDs.

Rheumatoid arthritis affects millions of Americans ... to reduce pain and inflammation Disease-modifying antirheumatic drugs (DMARDs) like methotrexate to slow disease progression Lifestyle ...

If this medication doesn't work for you, your healthcare provider may switch to a biologic medication or add additional DMARDs to your treatment plan. Rheumatoid arthritis progression can vary ...